Clinical Trial Update: Diagnostic Accuracy of SurePath™ in EUS-FNA

View source ↗

Summary

A clinical trial evaluating the diagnostic accuracy of SurePath in EUS-FNA for gastrointestinal submucosal tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Submucosal Tumor

Snippet

Sponsor: Seoul National University Hospital | Conditions: Submucosal Tumor of Gastrointestinal Tract | Status: TERMINATED